Home > Healthcare > Drug Device Combination > Therapeutic Systems > Plantar Fasciitis Treatment Market
Plantar Fasciitis Treatment Market Size
- Report ID: GMI8660
- Published Date: Mar 2024
- Report Format: PDF
Plantar Fasciitis Treatment Market Size
Plantar Fasciitis Treatment Market size was valued at around USD 1.2 billion in 2023 and is estimated to reach over USD 2.7 billion by 2032 with a CAGR of 9.3% over the forecast period. This robust market growth can be attributed to various factors, including ongoing advancements in technology, an increase in the prevalence of plantar fasciitis, a rising demand for minimally invasive procedures, the continual growth of healthcare expenditure, and an escalating awareness among patients and healthcare providers, among other contributing factors.
Moreover, plantar fasciitis is one of the most common causes of heel pain, affecting millions of individuals worldwide. The high prevalence of plantar fasciitis drives the demand for effective treatment options among patients seeking relief from symptoms such as heel pain, inflammation, and stiffness. As the incidence of risk factors such as obesity, physical activity, and age-related changes in foot structure continues to rise, the prevalence of plantar fasciitis is expected to increase, fueling growth in the market.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Plantar Fasciitis Treatment Market Size in 2023: | USD 1.2 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 9.3% |
| 2032 Value Projection: | USD 2.7 Billion |
| Historical Data for: | 2018 – 2023 |
| No. of Pages: | 230 |
| Tables, Charts & Figures: | 441 |
| Segments covered: | Treatment Type, Indication, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
For instance, as per the article published by Journal of Orthopaedic & Sports Physical Therapy, in 2023, plantar fasciitis accounted for approximately 15% of all foot pathologies in the general population and is most common in those aged 40 to 60.
Furthermore, continuous advancements in medical technology drive innovation in the treatment of plantar fasciitis, leading to the development of novel and more effective treatment modalities. These advancements include the use of shockwave therapy devices, radiofrequency ablation, ultrasound-guided procedures, and regenerative medicine techniques such as platelet-rich plasma (PRP) therapy and stem cell therapy. Technological advancements improve treatment outcomes, reduce recovery times, and minimize complications, driving adoption rates among patients and healthcare providers, thereby contributing to the growth of the market.
Plantar fasciitis treatment refers to the various therapeutic interventions aimed at alleviating symptoms and addressing the underlying causes of plantar fasciitis, a common foot condition characterized by inflammation and irritation of the plantar fascia, the thick band of tissue that runs along the bottom of the foot, connecting the heel bone to the toes.
Frequently Asked Questions (FAQ) :
Plantar Fasciitis Treatment Market Scope
